SYS-CON MEDIA Authors: Jayaram Krishnaswamy, Lori MacVittie, Gilad Parann-Nissany, Unitiv Blog, Bob Gourley

News Feed Item

Edwards Lifesciences to Present at the Credit Suisse 2012 Healthcare Conference

IRVINE, CA -- (Marketwire) -- 11/07/12 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Credit Suisse 2012 Healthcare Conference at the Arizona Biltmore Hotel in Phoenix, Arizona on Wednesday, November 14, 2012.

Thomas M. Abate, Edwards Lifesciences' corporate vice president, chief financial officer, is scheduled to speak to conference attendees at 10:30 a.m. MST (12:30 p.m. EST). A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.

Media Contact:
Sarah Huoh
949-250-5070

Investor Contact:
David K. Erickson
949-250-6826

Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA USA 92614
Phone: 949.250.2500
Fax: 949.250.2525
www.edwards.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.